GWAS and drug targets

BMC Genomics

Volumn 15, Issue , 2014, Pages

  Cao, Chen ^a,b   Moult, John ^a,c  

^a UNIVERSITY OF MARYLAND   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

^c University of Maryland   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; CD123 ANTIGEN; CD4 ANTIGEN; CYCLIN D1; EPIDERMAL GROWTH FACTOR RECEPTOR; EPIDERMAL GROWTH FACTOR RECEPTOR 2; ETANERCEPT; FATTY ACID SYNTHASE; FIBROBLAST GROWTH FACTOR RECEPTOR 1; FIBROBLAST GROWTH FACTOR RECEPTOR 2; FIBROBLAST GROWTH FACTOR RECEPTOR 3; HISTONE DEACETYLASE 1; INSULIN RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR GAMMA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PALIFERMIN; PONATINIB; PROTEIN RET; RAF PROTEIN; SYNDECAN 2; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2; DRUG;

ARTICLE; DRUG REPOSITIONING; DRUG TARGETING; FALSE POSITIVE RESULT; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC TRANSCRIPTION; GENOME-WIDE ASSOCIATION STUDY; MACHINE LEARNING; MEASUREMENT PRECISION; ONCOGENE RET; PHENOTYPE; PREDICTION; PROTEIN INTERACTION; RECEIVER OPERATING CHARACTERISTIC; SINGLE NUCLEOTIDE POLYMORPHISM; CHEMISTRY; DISEASES; DRUG DELIVERY SYSTEM; GENE REGULATORY NETWORK; GENETIC ASSOCIATION; GENETICS; HUMAN; HUMAN GENOME; METABOLISM;

DISEASE; DRUG DELIVERY SYSTEMS; GENE REGULATORY NETWORKS; GENOME, HUMAN; GENOME-WIDE ASSOCIATION STUDY; HUMANS; PHARMACEUTICAL PREPARATIONS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84925282741     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-15-S4-S5     Document Type: Article

References (41)

1. Corvin A, Craddock N, Sullivan P: Genome-wide association studies: a primer. Psychological medicine 2010, 40(7):1063.
2. Johnson AD, Newton-Cheh C, Chasman DI, Ehret GB, Johnson T, Rose L, Rice K, Verwoert GC, Launer LJ, Gudnason V, et al: Association of hypertension drug target genes with blood pressure and hypertension in 86, 588 individuals. Hypertension 2011, 57(5):903-910.
3. Ehret GB: Genome-wide association studies: contribution of genomics to understanding blood pressure and essential hypertension. Curr Hypertens Rep 2010, 12(1):17-25.
4. Takahashi N, Smithies O: Human genetics, animal models and computer simulations for studying hypertension. Trends Genet 2004, 20(3):136-145.
5. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, Manolio TA: Potential etiologic and functional implications of genomewide association loci for human diseases and traits. Proc Natl Acad Sci USA 2009, 106(23):9362-9367.
6. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, et al: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Nucleic Acids Res 2011, 39(Database):D1035-1041.
7. Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nature reviews Drug discovery 2006, 5(12):993-996.
8. Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nature reviews Drug discovery 2006, 5(10):821-834.
9. Durbin R, Altshuler D, Brooks L, Felsenfeld A, McEwen J: 1000 Genomes Project: A Deep Catalog of Human Genetic Variation. January; 2010.
10. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN: Human Gene Mutation Database (HGMD): 2003 update. Hum Mutat 2003, 21(6):577-581.
11. Kimura M: Preponderance of synonymous changes as evidence for the neutral theory of molecular evolution. Nature 1977, 267(5608):275-276.
12. Yamasaki C, Murakami K, Fujii Y, Sato Y, Harada E, Takeda J-i, Taniya T, Sakate R, Kikugawa S, Shimada M: The H-Invitational Database (H-InvDB), a comprehensive annotation resource for human genes and transcripts. Nucleic acids research 2008, 36(Database):D793.
13. Jia P, Zhao Z: Network-assisted Causal Gene Detection in Genome-wide Association Studies: An Improved Module Search Algorithm. IEEE Int Workshop Genomic Signal Process Stat 2011, 131-134.
14. Jia P, Wang L, Fanous AH, Pato CN, Edwards TL, Zhao Z: Network-assisted investigation of combined causal signals from genome-wide association studies in schizophrenia. PLoS Comput Biol; 2012:8(7):e1002587.
15. Yeh SH, Yeh HY, Soo VW: A network flow approach to predict drug targets from microarray data, disease genes and interactome network-case study on prostate cancer. J Clin Bioinforma 2012, 2(1):1.
16. Ciriello G, Cerami E, Sander C, Schultz N: Mutual exclusivity analysis identifies oncogenic network modules. Genome Res 2012, 22(2):398-406.
17. Rossin EJ, Lage K, Raychaudhuri S, Xavier RJ, Tatar D, Benita Y, Cotsapas C, Daly MJ: Proteins encoded in genomic regions associated with immunemediated disease physically interact and suggest underlying biology. PLoS Genet 2011, 7(1):e1001273.
18. Breitkreutz BJ, Stark C, Reguly T, Boucher L, Breitkreutz A, Livstone M, Oughtred R, Lackner DH, Bahler J, Wood V, et al: The BioGRID Interaction Database: 2008 update. Nucleic Acids Res 2008, 36(Database):D637-640.
19. Chatr-Aryamontri A, Ceol A, Palazzi LM, Nardelli G, Schneider MV, Castagnoli L, Cesareni G: MINT: the Molecular INTeraction database. Nucleic Acids Res 2007, 35:(Database issue):D572-574.
20. Kanehisa M, Goto S, Kawashima S, Okuno Y, Hattori M: The KEGG resource for deciphering the genome. Nucleic Acids Res 2004, 32:(Database issue): D277-280.
21. Wu G, Feng X, Stein L: A human functional protein interaction network and its application to cancer data analysis. Genome Biol 2010, 11(5):R53.
22. Lee HK, Hsu AK, Sajdak J, Qin J, Pavlidis P: Coexpression analysis of human genes across many microarray data sets. Genome Res 2004, 14(6):1085-1094.
23. Prieto C, Risueno A, Fontanillo C, De las Rivas J: Human gene coexpression landscape: confident network derived from tissue transcriptomic profiles. PLoS One 2008, 3(12):e3911.
24. Verspoor K, Cohen KB, Lanfranchi A, Warner C, Johnson HL, Roeder C, Choi JD, Funk C, Malenkiy Y, Eckert M: A corpus of full-text journal articles is a robust evaluation tool for revealing differences in performance of biomedical natural language processing tools. BMC Bioinformatics 2012, 13(1):207.
25. Fire M, Tenenboim L, Lesser O, Puzis R, Rokach L, Elovici Y: Link prediction in social networks using computationally efficient topological features. Privacy, security, risk and trust (passat), 2011 ieee third international conference on and 2011 ieee third international conference on social computing (socialcom): 2011 IEEE; 2011, 73-80.
26. Carley DW: Drug repurposing: identify, develop and commercialize new uses for existing or abandoned drugs. Part II. IDrugs: the investigational drugs journal 2005, 8(4):310.
27. Witten IH, Frank E, Trigg LE, Hall MA, Holmes G, Cunningham SJ: Weka: Practical machine learning tools and techniques with Java implementations. 1999.
28. Korb LC, Ahearn JM: C1q binds directly and specifically to surface blebs of apoptotic human keratinocytes: complement deficiency and systemic lupus erythematosus revisited. The Journal of Immunology 1997, 158(10):4525-4528.
29. Walport MJ, Davies KA, Botto M: C1q and systemic lupus erythematosus. Immunobiology 1998, 199(2):265-285.
30. Bowness P, Davies K, Norsworthy P, Athanassiou P, Taylor-Wiedeman J, Borysiewicz L, Meyer P, Walport M: Hereditary C1q deficiency and systemic lupus erythematosus. QJM 1994, 87(8):455-464.
31. Laxer R, Cameron B, Silverman E: Occurrence of Kawasaki disease and systemic lupus erythematosus in a single patient. The Journal of rheumatology 1988, 15(3):515.
32. Diniz J, Almeida R, Aikawa N, Sallum A, Sakane P, Silva C: Kawasaki disease and juvenile systemic lupus erythematosus. Lupus 2012, 21(1):89-92.
33. Gattei V, Degan M, Aldinucci D, De Iuliis A, Rossi FM, Mazzocco FT, Rupolo M, Zagonel V, Pinto A: Differential expression of the RET gene in human acute myeloid leukemia. Annals of hematology 1998, 77(5):207-210.
34. Imanishi T, Nakaoka H: Hyperlink Management System and ID Converter System: enabling maintenance-free hyperlinks among major biological databases. Nucleic Acids Res 2009, 37(Web Server):W17-22.
35. Floyd RW: Algorithm 97: shortest path. Communications of the ACM 1962, 5(6):345.
36. Domingos P: MetaCost: a general method for making classifiers costsensitive. Proceedings of the fifth ACM SIGKDD international conference on Knowledge discovery and data mining: 1999 ACM; 1999, 155-164.
37. Sanseau P, Agarwal P, Barnes MR, Pastinen T, Richards JB, Cardon LR, Mooser V: Use of genome-wide association studies for drug repositioning. Nature biotechnology 2012, 30(4):317-320.
38. Wang ZY, Zhang HY: Rational drug repositioning by medical genetics. Nature biotechnology 2013, 31(12):1080-1082.
39. Tennessen JA, Bigham AW, O'Connor TD, Fu W, Kenny EE, Gravel S, McGee S, Do R, Liu X, Jun G, et al: Evolution and functional impact of rare coding variation from deep sequencing of human exomes. Science 2012, 337(6090):64-69.
40. Kiezun A, Garimella K, Do R, Stitziel NO, Neale BM, McLaren PJ, Gupta N, Sklar P, Sullivan PF, Moran JL: Exome sequencing and the genetic basis of complex traits. Nature genetics 2012, 44(6):623-630.
41. Nelson MR, Wegmann D, Ehm MG, Kessner D, Jean PS, Verzilli C, Shen J, Tang Z, Bacanu S-A, Fraser D: An abundance of rare functional variants in 202 drug target genes sequenced in 14, 002 people. Science 2012, 337(6090):100-104.